BBC

BioShares Biotechnology Clinical Trials ETF

Down$27.86
$-0.35
(-1.24%)
As of 8:00:00 PM EDT | 7/23/19  |  Market Closed

BBC Trading Data

Open

$28.16

Low Price

$27.86

High Price

$28.16

Previous Last Price

$28.22

Bid Size

$0 X 0

Ask Size

$0 X 0

BBC Portfolio Data

AUM

$26,866,000

Shares

950

PE Ratio

7.55

Price / Book Ratio

3.21

Expense Ratio

0.79

Net Asset Value

$28.28

Volume

Volume

3,500

Avg. Volume (YDT)

6,620

Dollar Volume

$86,986

Weekly Avg. Volume

2,680

Monthly Avg. Volume

3,670

Quarterly Avg. Volume

3,641

BBC Fund Description

The BioShares Biotechnology Clinical Trials Fund seeks investment results that correspond to the performance of the BioShares Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drugs.

BBC Chart

BBC Summary

Fund Family

BioShares

Tracks This Index

BioShares Biotechnology Clinical Trials ETF

Inception Date

2014-12-17

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

BBC Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

BBC Holdings

Top 10 Holdings

Krystal Biotech Inc (KRYS)
1.75%
Avrobio Inc (AVRO)
1.71%
Ra Pharmaceuticals Inc (RARX)
1.6%
Karyopharm Therapeutics Inc (KPTI)
1.45%
Xencor Inc (XNCR)
1.44%
G1 Therapeutics Inc (GTHX)
1.35%
MeiraGTx Holdings plc (MGTX)
1.34%
Iovance Biotherapeutics Inc (IOVA)
1.33%
Cara Therapeutics Inc (CARA)
1.29%
Progenics Pharmaceuticals Inc (PGNX)
1.29%

Total BBC Holdings

Total Holdings: 98

Krystal Biotech Inc (KRYS)
1.75%
Avrobio Inc (AVRO)
1.71%
Ra Pharmaceuticals Inc (RARX)
1.6%
Karyopharm Therapeutics Inc (KPTI)
1.45%
Xencor Inc (XNCR)
1.44%
G1 Therapeutics Inc (GTHX)
1.35%
MeiraGTx Holdings plc (MGTX)
1.34%
Iovance Biotherapeutics Inc (IOVA)
1.33%
Cara Therapeutics Inc (CARA)
1.29%
Progenics Pharmaceuticals Inc (PGNX)
1.29%
Sangamo Therapeutics Inc (SGMO)
1.29%
Apellis Pharmaceuticals Inc (APLS)
1.28%
ArQule Inc (ARQL)
1.28%
Synthorx Inc (THOR)
1.27%
Adverum Biotechnologies Inc (ADVM)
1.26%
Fate Therapeutics Inc (FATE)
1.25%
Immunomedics Inc (IMMU)
1.22%
Bluebird Bio Inc (BLUE)
1.19%
Arvinas Inc (ARVN)
1.17%
CytomX Therapeutics Inc (CTMX)
1.16%
Cytokinetics Inc (CYTK)
1.16%
FibroGen Inc (FGEN)
1.16%
ImmunoGen Inc (IMGN)
1.15%
MyoKardia Inc (MYOK)
1.15%
Principia Biopharma Inc (PRNB)
1.14%
Eidos Therapeutics Inc (EIDX)
1.14%
Arrowhead Pharmaceuticals Inc (ARWR)
1.13%
Acceleron Pharma Inc (XLRN)
1.13%
Mirati Therapeutics Inc (MRTX)
1.11%
Arena Pharmaceuticals Inc (ARNA)
1.11%
Denali Therapeutics Inc (DNLI)
1.1%
Axsome Therapeutics Inc (AXSM)
1.1%
Epizyme Inc (EPZM)
1.09%
PTC Therapeutics Inc (PTCT)
1.08%
TG Therapeutics Inc (TGTX)
1.08%
Athenex Inc (ATNX)
1.08%
Blueprint Medicines Corp (BPMC)
1.07%
ZIOPHARM Oncology Inc (ZIOP)
1.07%
Viking Therapeutics Inc (VKTX)
1.06%
Dicerna Pharmaceuticals Inc (DRNA)
1.06%
Allogene Therapeutics Inc (ALLO)
1.05%
Reata Pharmaceuticals Inc (RETA)
1.05%
Global Blood Therapeutics Inc (GBT)
1.05%
Prothena Corp PLC (PRTA)
1.05%
GlycoMimetics Inc (GLYC)
1.05%
BeiGene Ltd (BGNE)
1.05%
Kura Oncology Inc (KURA)
1.05%
Gritstone Oncology Inc (GRTS)
1.04%
REGENXBIO Inc (RGNX)
1.02%
BioCryst Pharmaceuticals Inc (BCRX)
1.01%
uniQure NV (QURE)
1.01%
Cymabay Therapeutics Inc (CBAY)
1.01%
Autolus Therapeutics PLC (AUTL)
1.01%
Voyager Therapeutics Inc (VYGR)
1%
Audentes Therapeutics Inc (BOLD)
0.99%
Myovant Sciences Ltd (MYOV)
0.99%
MacroGenics Inc (MGNX)
0.98%
ChemoCentryx Inc (CCXI)
0.98%
Madrigal Pharmaceuticals Inc (MDGL)
0.97%
Gossamer Bio Inc (GOSS)
0.96%
Tricida Inc (TCDA)
0.96%
Akcea Therapeutics Inc (AKCA)
0.96%
Assembly Biosciences Inc (ASMB)
0.95%
Deciphera Pharmaceuticals Inc (DCPH)
0.95%
Ascendis Pharma A/S (ASND)
0.95%
Orchard Therapeutics plc (ORTX)
0.94%
Agenus Inc (AGEN)
0.94%
Rhythm Pharmaceuticals Inc (RYTM)
0.93%
Magenta Therapeutics Inc (MGTA)
0.93%
Intra-Cellular Therapies Inc (ITCI)
0.93%
WaVe Life Sciences Ltd (WVE)
0.93%
Akebia Therapeutics Inc (AKBA)
0.93%
Alector Inc (ALEC)
0.92%
Moderna Inc (MRNA)
0.91%
Insmed Inc (INSM)
0.91%
Corbus Pharmaceuticals Holdings Inc (CRBP)
0.89%
Aimmune Therapeutics Inc (AIMT)
0.89%
La Jolla Pharmaceutical Co (LJPC)
0.89%
Esperion Therapeutics Inc (ESPR)
0.89%
UNITY Biotechnology Inc (UBX)
0.88%
PhaseBio Pharmaceuticals Inc (PHAS)
0.88%
KalVista Pharmaceuticals Inc (KALV)
0.87%
Achillion Pharmaceuticals Inc (ACHN)
0.86%
Alder Biopharmaceuticals Inc (ALDR)
0.83%
Geron Corp (GERN)
0.83%
Forty Seven Inc (FTSV)
0.82%
Sorrento Therapeutics Inc (SRNE)
0.81%
Rocket Pharmaceuticals Inc (RCKT)
0.8%
ProQR Therapeutics NV (PRQR)
0.77%
AnaptysBio Inc (ANAB)
0.75%
Allakos Inc (ALLK)
0.75%
Amyris Inc (AMRS)
0.73%
Abeona Therapeutics Inc (ABEO)
0.73%
Biohaven Pharmaceutical Holding Co Ltd (BHVN)
0.7%
Atara Biotherapeutics Inc (ATRA)
0.69%
BNY MELLON CASH RESERVE USD
0.37%
Virtus LifeSci Biotech Clinical Trials ETF (BBC)
0%
Cash/Cash equivalents
0%

BBC Technicals

Alpha

-2.04

Beta

1.75

Leverage

Long

Standard Deviation

3.51

BBC Dividends

Dividend Date

2017-12-20

Latest Dividend

0.297

Annual Dividend

0

Annual Dividend Rate

0

Annual Dividend Yield

1.0E-5

BBC Performance

YTD Return

19.95%

1 Year Return

-18.12%

3 Year Return

40.03%

5 Year Return

0%

10 Year Return

1.72%

BBC Related Articles